This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Day, P. M.
Right arrow Articles by Schiller, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Day, P. M.
Right arrow Articles by Schiller, J. T.

 Previous Article  |  Next Article 

Journal of Virology, May 2008, p. 4638-4646, Vol. 82, No. 9
0022-538X/08/$08.00+0     doi:10.1128/JVI.00143-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies{triangledown}

Patricia M. Day,1* Ratish Gambhira,2 Richard B. S. Roden,2 Douglas R. Lowy,1 and John T. Schiller1

Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland,1 Department of Pathology, Johns Hopkins University, Baltimore, Maryland2

Received 18 January 2008/ Accepted 19 February 2008

Pseudovirions of human papillomavirus type 16 (HPV16), the principal etiologic agent in 50% of cervical cancers, were used as a model system to investigate the cell surface interactions involved in the exposure of the broadly cross-neutralizing papillomavirus L2 epitopes. These neutralizing epitopes were exposed only after cell surface binding and a subsequent change in capsid conformation that permitted cleavage by the cellular protease furin at a specific highly conserved site in L2 that is immediately upstream of the cross-neutralizing epitopes. Unexpectedly, binding of L2 antibodies led to the release of the capsid/antibody complexes from the cell surface and their accumulation on the extracellular matrix. Study of the dynamics of exposure of the L2 epitopes further revealed that representatives of the apparently dominant class of L1-specific neutralizing antibodies induced by virus-like particle vaccination prevent infection, not by preventing cell surface binding but rather by preventing the conformation change involved in exposure of the L2 neutralizing epitope. These findings suggest a dynamic model of virion-cell surface interactions that has implications for both evolution of viral serotypes and the efficacy of current and future HPV vaccines.

* Corresponding author. Mailing address: 37 Convent Drive, Room 4112, MSC 4263, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 594-6945. Fax: (301) 480-5322. E-mail: pmd{at}nih.gov

{triangledown} Published ahead of print on 27 February 2008.

Journal of Virology, May 2008, p. 4638-4646, Vol. 82, No. 9
0022-538X/08/$08.00+0     doi:10.1128/JVI.00143-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Conway, M. J., Alam, S., Ryndock, E. J., Cruz, L., Christensen, N. D., Roden, R. B. S., Meyers, C. (2009). Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions. J. Virol. 83: 10515-10526 [Abstract] [Full Text]  
  • Laniosz, V., Dabydeen, S. A., Havens, M. A., Meneses, P. I. (2009). Human Papillomavirus Type 16 Infection of Human Keratinocytes Requires Clathrin and Caveolin-1 and Is Brefeldin A Sensitive. J. Virol. 83: 8221-8232 [Abstract] [Full Text]  
  • Jagu, S., Karanam, B., Gambhira, R., Chivukula, S. V., Chaganti, R. J., Lowy, D. R., Schiller, J. T., Roden, R. B. S. (2009). Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines. JNCI J Natl Cancer Inst 101: 782-792 [Abstract] [Full Text]  
  • Day, P. M., Lowy, D. R., Schiller, J. T. (2008). Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus Capsids. J. Virol. 82: 12565-12568 [Abstract] [Full Text]  
  • Lowy, D., Day, P., Kines, R., Roberts, J., Thompson, C., Pang, S., Buck, C., Roden, R., Schiller, J. (2008). Abstract LE01: DISTINGUISHED LECTURE ON TARGETS FOR CANCER PREVENTION: Prevention of cervical cancer in current and future generations by HPV vaccination and other approaches. Cancer Prevention Research 1: LE01-LE01  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»